![](/img/cover-not-exists.png)
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial
Winkel, Per, Hilden, Jørgen, Hansen, Jørgen Fischer, Kastrup, Jens, Kolmos, Hans Jørn, Kjøller, Erik, Jensen, Gorm Boje, Skoog, Maria, Lindschou, Jane, Gluud, ChristianVolume:
182
Language:
english
Journal:
International Journal of Cardiology
DOI:
10.1016/j.ijcard.2015.01.020
Date:
March, 2015
File:
PDF, 378 KB
english, 2015